BaltaSMikhailidisDPDemirkolS. Endocan—a novel inflammatory indicator in newly diagnosed patients with hypertension: A pilot study. Angiology. 2014;65(9):773–777.
2.
LassallePMoletSJaninA. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 1996;271(34):20458–20464.
3.
PacherPMukhopadhyayPMohanrajRGodlewskiGBatkaiSKunosG. Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. Hypertension. 2008;52(4):601–607.
4.
AdamESarrazinSLandolfiC. Efficient long-term and high-yielded production of a recombinant proteoglycan in eukaryotic HEK293 cells using a membrane-based bioreactor. Biochem Biophys Res Commun. 2008;369(2):297–302.
5.
AbidMRYiXYanoKShihSCAirdWC. Vascular endocan is preferentially expressed in tumor endothelium. Microvasc Res. 2006;72(3):136–145.
6.
AkkökCAHervigTStamnesfetS. Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma. Cytotherapy. 2011;13(10):1259–1268.
7.
RennelEMellbergSDimbergA. Endocan is a VEGF-A and PI3 K regulated gene with increased expression in human renal cancer. Exp Cell Res. 2007;313(7):1285–1294.
8.
ZuoLZhangSMHuRL. Correlation between expression and differentiation of endocan in colorectal cancer. World J Gastroenterol. 2008;14(28):4562–4568.
9.
ZhangSMZuoLZhouQ. Expression and distribution of endocan in human tissues. Biotech Histochem. 2012;87(3):172–178.
10.
RoudnickyFPoyetCWildP. Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res. 2013;73(3):1097–1106.
11.
LeroyXAubertSZiniL. Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology. 2010;56(2):180–187.
12.
HatfieldKJLassallePLeivaRALindasRWendelboeOBruserudO. Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia. Hematology. 2011;16(6):351–356.
13.
GrigoriuBDDepontieuFScherpereelA. Endocan expression and relationship with survival in human non-small cell lung cancer. Clin Cancer Res. 2006;12(15):4575–4582.
14.
ChenLYLiuXWangSLQinCY. Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. J Int Med Res. 2010;38(2):498–510.
15.
ScherpereelAGentinaTGrigoriuB. Overexpression of endocan induces tumor formation. Cancer Res. 2003;63(18):6084–6089.
16.
SarrazinSAdamELyonM. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta. 2006;1765(1):25–37.
17.
DepontieuFGrigoriuBDScherpereelA. Loss of Endocan tumorigenic properties after alternative splicing of exon 2. BMC Cancer. 2008;8:14.
18.
BaltaIBaltaSDemirkolS. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol. 2013.
19.
BaltaIBaltaSKoryurekOM. Serum endocan levels as a marker of disease activity in patients with Behcet disease. J Am Acad Dermatol. 2013;169(5):1066–1070. doi: pii: S0190-9622(13)00964-X. 10.1016/j.jaad.2013.09.013.
